hotspot -WSS

hotspot

author：focus 2025-09-06 03:17:17 - browse：7442

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Hospitals look to new technology to keep health care workers safe

hotspot

WSS

Deposition: Sackler embraced plan to conceal OxyContin’s strength

PBM reforms clear House panel

Surge of respiratory disease in China has likely explanation

5 takeaways from STAT's examination of Zynex Medical

Cigna wins case to block Amy Bricker's move to CVS

David Sabatini, ex

focus

hotspot

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

5 takeaways from STAT's examination of Zynex Medical

Alkermes shareholders re

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

California wildfire smoke linked to 52,000 early deaths, study says

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Childhood cancer progress stalls for Black, Hispanic kids: Report

Drug repurposing or repositioning? The language matters

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

knowledge

Does good food count as health care? Study aims to find out

Surge of respiratory disease in China has likely explanation

5 takeaways from STAT's examination of Zynex Medical

Weight loss drug costs may need more research, senator suggests

Wegovy, Zepbound and weight loss drugs that preserve muscle

Stephen Quake on the Chan Zuckerberg quest to conquer disease

focus

Wikipedia

hotspot

Wikipedia